Cart (0 Items)
Your cart is currently empty.
View Products
Elevate your research with our custom antibody solutions designed to deliver results fast. Benefit from a vast expertise of over 4,000+ monoclonal and 6,000+ polyclonal antibodies produced, and experience seamless antibody development—from antigen preparation to final production. Our advanced platforms, including hybridoma generation, B-cell sorting, and phage display, ensure you receive high-quality antibodies in less than a month. Unlock the potential of your therapeutic, diagnostic, and research applications with our expertise, even against the most challenging antigens.
Accelerate your custom antibody development project using our wide range of solutions.
Simplify your antibody production project with our recombinant antibody production services.
Transform your monoclonal antibody into a powerful therapeutic by:
Interrogate the biophysical features of your candidate biologic using our comprehensive suite of antibody characterization services:
At ProteoGenix, custom antibody development isn’t just one of our services — it’s our core expertise. With years of experience, we’ve built dedicated platforms and tailored solutions to address the specific needs of each sector: therapeutics, diagnostics, research, and animal health.
We specialize in the generation of human antibodies using phage display or humanized mouse models.
Our custom antibodies are fully optimized and guaranteed to perform in your selected application:
We develop species-specific antibodies for cats, dogs, and rabbits using multiple strategic approaches:
Innovation begins with tailored solutions. With a focus on quality, reliability, and fast turnaround times, we provide you with a full spectrum of custom antibody services designed to meet your project’s unique objectives, whether it’s developing an antibody from scratch or enhancing an existing antibody to optimize its performance.
One-Stop Solution & Integrated Full-Range Services
Gain peace of mind knowing all aspects of your antibody development project, from antigen design to antibody production, can be efficiently and seamlessly accomplished by the same expert team.
Freedom to Operate
Secure your intellectual property rights and maintain complete ownership of your assets.
10000+ antibodies produced
With 25 years of experience and over 10,000 antibodies produced, trust our experts to deliver excellence.
Proprietary platforms
We provide an added-value at each step of your antibody development process thanks to our various proprietary platforms: RocketAbsTM, MultiMabXpressTM, XtenCHOTM…
Solutions for your application
Whether you are developing antibodies for therapeutic, veterinary, diagnostic, or research applications, we have tailored solutions to meet your needs.
Experts in difficult-to-express antigen
Working on a challenging target? We have expertise in producing difficult-to-express antigens such as GPCRs or MHC-peptide complexes…
Innovation begins with tailored solutions. With a focus on quality, reliability, and fast turnaround times, we provide you with a full spectrum of custom antibody services designed to meet your project’s unique objectives, whether it’s developing an antibody from scratch or enhancing an existing antibody to optimize its performance.
Accelerate your custom antibody development project using our wide range of solutions.
The best compromise between diversity and developability.
Benefit from the most complete collection of antibody libraries
At ProteoGenix, our mission is to tackle all your antibody generation challenges, no matter how ambitious. Here are just a few examples of how we can support your projects:
These examples illustrate the breadth of our capabilities, but the true strength of our platform lies in its diversity, allowing us to always find the perfect solution for your project without compromise.
At ProteoGenix, we understand the regulatory, economic, and time constraints involved in antibody production, whether for therapeutic, diagnostic, or research purposes. That’s why we’ve developed three cutting-edge antibody production platforms to meet your specific needs.
Express your antibodies at the mg to g level with the best expression system on the market XtenCHOTM!
Discover MultimAbXpressTM, our proprietary platform for the production of hundreds of antibodies in parallel
The most productive IP free cell line development service
In scientific research, challenges abound, but so do opportunities for innovation. Our case studies highlight the real-world impact of our experts and custom antibody services. As researchers ourselves, we understand the importance of translating ideas into tangible results.
Through these narratives, we invite you to step behind the scenes and witness firsthand how Proteogenix’s tailored approach has transformed obstacles into solutions.
“I requested ProteoGenix’s services for the generation of an anti-peptide monoclonal antibody to be used in my research. I required the antibody primarily for western blotting and immunoprecipitation experiments. Although the peptide antigen proved challenging in terms of immunogenicity, ProteoGenix was able to propose a range of customised strategies to overcome production issues encountered and finally succeeded in generating not only one but three antibodies of interest, thus offering me extra options in terms of final choice and use. During the whole project, Proteogenix strived to ensure maximal quality and to adapt to my needs, and my Account Manager always provided prompt and helpful services and solutions. I can highly commend both the level of expertise and the service I received.”
Dr. David Pryce, Lecturer in Biomedical Sciences (Immunology), Bangor University, UK
“I highly recommend ProteoGenix for their fast and efficient services, providing top-quality antibodies suitable for diverse applications. Their exceptional communication, quick turnaround time, and reasonable pricing make them an excellent choice even for non-standard projects.”
Dr. Anna Blom, Professor, Lund University, Sweden
“We requested ProteoGenix’s services for the development of antibodies against a specific surface protein by phage display. Their naive human library was built from 368 donors for maximized diversity. This unique quality and their reactivity convinced us to work with them. They successfully identified various candidates that all bound well and specifically to our antigen. I appreciated their expertise for the high quality of their services as well as their good responses to my questions for this project.”
Naoya Uchida, M.D., Ph.D. at The Institute of Medical Science, The University of Tokyo, Japan
“I requested ProteoGenix’s services for the generation of neutralizing anti-COVID-19 antibodies by Phage Display. They designed an optimised strategy for this purpose which led to great results, with 4 antibodies identified as cross-reactive and neutralizing against all the current variants of concerns. During the whole project, Proteogenix strived to ensure the best quality of their final deliverables, especially by including additional screenings against emerging variants as the pandemic evolved. Their proactivity was key to obtaining promising and relevant blocking antibodies in only a few months. I highly recommend them for both their level of expertise and the personalised service they offer.”
Khelan Patel, Managing Director, Trident Biopharm Solutions, London, UK
“We are developing a novel immunotherapy and needed a highly potent monoclonal antibody. Currently the development of a novel antibody requires lengthy and expensive humanization process. We thus decided to screen for binders a human antibody library via phage display screening instead of humanizing a murine antibody. Proteogenix proposed just that. We provided our purified target antigen and in only one month several high affinity binders were obtained. We were able to quickly clone and produce a monoclonal antibody from the sequences provided. What should have taken 6 to 8 months was done in 2 for a fraction of the cost and for an equivalent quality.”
Dr. Abbas El Sahili, Senior Research Fellow, Nanyang Technological University, Singapore
Founded in 2003, ProteoGenix initially focused on developing diagnostic assays and biotherapeutics targeting discovered proteins. Recognizing the value of high-quality antibodies and proteins, ProteoGenix ventured into the biopharmaceutical domain, aiming to facilitate access to clinical settings, becoming a leading antibody production company.
ProteoGenix quickly gained recognition as a trusted Contract Research Organization (CRO) and a preferred partner in the biopharmaceutical industry. Its expertise in therapeutic antibodies and custom assay development significantly enhanced the success rate of its customized therapeutics, diagnostics, as well as research tools, thereby accelerating publications, reducing time-to-market and facilitating investigational stage of new drug application.
ProteoGenix is more than just an antibody production company. It also serves as a service integrator, guiding customers from early discovery to the clinic by anticipating future biologics requirements and designing tailor-made development strategies to proactively meet those needs. Its extensive portfolio of innovative solutions spans the following six complementary service areas:
Our research and development labs constantly influence our processes with outstanding innovations like our proprietary XtenCHO™ cell line for industry-leading antibody expression in mammalian cells.
ProteoGenix also boasts an extensive catalog of over 7,000 products available in their user-friendly online shop. This comprehensive collection encompasses antibodies, proteins, ELISA kits, cell separation media, and nucleic acid purification kits, ensuring easy access to a wide range of research tools.
Got a question or need a quote? Message us and we’ll get back to you 48 hours or less.